|
|
Article: Materia Announces NIH Funding for the Development of Advanced Reagent System for Drug Discovery.
- Article from:
- Business Wire
- Article date:
- October 23, 2006
CopyrightCOPYRIGHT 2006 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
PASADENA, Calif. -- Materia has announced NIH funding for the further development of a metathesis-enabled reagent system for drug discovery.
The program, jointly conducted with Dr. Paul Hanson at the University of Kansas through a National Institutes of Health Small Business Technology Transfer (STTR) grant, will use Materia's proprietary Ring Opening Metathesis (ROM) catalysts to generate broadly-applicable reagents and matrices for drug development. These tools will be used by pharmaceutical researchers to aid compound design via efficient modification of functional handles, as well as simplifying the resulting compounds' purification.
"Drug discovery ...